Original language | English |
---|---|
Pages (from-to) | 381-385 |
Number of pages | 5 |
Journal | American journal of respiratory and critical care medicine |
Volume | 203 |
Issue number | 3 |
DOIs | |
State | Published - Feb 1 2021 |
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor for 24 weeks or longer in people with cystic fibrosis and one or more F508del alleles: Interim results of an open-label phase 3 clinical trial
Matthias Griese, Stefano Costa, Rachel W. Linnemann, Marcus A. Mall, Edward F. McKone, Deepika Polineni, Bradley S. Quon, Felix C. Ringshausen, Jennifer L. Taylor-Cousar, Nicholas J. Withers, Samuel M. Moskowitz, Cori L. Daines
Research output: Contribution to journal › Letter › peer-review
135
Scopus
citations